Linus Ho

4.1k total citations · 1 hit paper
57 papers, 3.1k citations indexed

About

Linus Ho is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Linus Ho has authored 57 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 27 papers in Surgery. Recurrent topics in Linus Ho's work include Gastric Cancer Management and Outcomes (21 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Esophageal Cancer Research and Treatment (17 papers). Linus Ho is often cited by papers focused on Gastric Cancer Management and Outcomes (21 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Esophageal Cancer Research and Treatment (17 papers). Linus Ho collaborates with scholars based in United States, China and Netherlands. Linus Ho's co-authors include James L. Abbruzzese, Peter W. T. Pisters, Jaffer A. Ajani, Arlene M. Correa, Banke Agarwal, Douglas B. Evans, Robert A. Wolff, Christopher H. Crane, Chusilp Charnsangavej and Jeffrey E. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Linus Ho

56 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

2008 533 citations Douglas B. Evans, Christopher H. Crane et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linus Ho United States	28	2.0k	1.5k	1.5k	604	559	57	3.1k
Robert Marsh United States	24	2.0k 1.0×	1.0k 0.7×	1.1k 0.7×	462 0.8×	490 0.9×	78	2.5k
Geneviève Monges France	30	3.0k 1.5×	1.2k 0.8×	1.5k 1.0×	644 1.1×	666 1.2×	77	4.3k
Harald Schmalenberg Germany	17	2.3k 1.1×	1.6k 1.0×	1.3k 0.9×	647 1.1×	573 1.0×	46	3.1k
Richard A. Burkhart United States	29	2.2k 1.1×	877 0.6×	1.0k 0.7×	515 0.9×	824 1.5×	133	2.9k
Terumasa Yamada Japan	27	1.4k 0.7×	1.2k 0.8×	1.4k 1.0×	676 1.1×	336 0.6×	148	2.9k
Osamu Kainuma Japan	20	1.6k 0.8×	789 0.5×	983 0.7×	412 0.7×	310 0.6×	80	2.1k
A. Hennipman Netherlands	21	1.6k 0.8×	884 0.6×	754 0.5×	470 0.8×	500 0.9×	39	2.6k
Toshio Nakagohri Japan	27	1.7k 0.9×	940 0.6×	1.5k 1.0×	607 1.0×	267 0.5×	159	2.9k
Klaus Gellert Germany	23	3.4k 1.7×	1.6k 1.1×	2.1k 1.4×	1.2k 1.9×	1.1k 2.0×	51	4.7k
Carl Zuelke Germany	9	2.2k 1.1×	807 0.5×	1.1k 0.8×	881 1.5×	689 1.2×	14	3.4k

Countries citing papers authored by Linus Ho

Since Specialization

Citations

This map shows the geographic impact of Linus Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linus Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linus Ho more than expected).

Fields of papers citing papers by Linus Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linus Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linus Ho. The network helps show where Linus Ho may publish in the future.

Co-authorship network of co-authors of Linus Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Linus Ho. A scholar is included among the top collaborators of Linus Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linus Ho. Linus Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goense, Lucas, Jelle P. Ruurda, Brett W. Carter, et al.. (2018). Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 45(10). 1742–1751. 22 indexed citations

Xi, Mian, Zhongxing Liao, Wayne L. Hofstetter, et al.. (2017). ¹⁸F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma. Journal of Nuclear Medicine. 58(11). 1756–1763. 15 indexed citations

Liao, Zhongxing, et al.. (2017). Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). 407–416. 7 indexed citations

Xi, Mian, Zhongxing Liao, Weiye Deng, et al.. (2017). A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer. Journal of Thoracic Oncology. 12(6). 1001–1010. 19 indexed citations

Badgwell, Brian D., Mariela A. Blum, Prajnan Das, et al.. (2017). Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Annals of Surgical Oncology. 24(11). 3338–3344. 93 indexed citations

He, Li-Ru, Wei Qiao, Zhongxing Liao, et al.. (2015). Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer. 15(1). 1095–1095. 13 indexed citations

Badgwell, Brian D., Jaffer A. Ajani, Mariela A. Blum, et al.. (2015). Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy. Annals of Surgical Oncology. 23(1). 156–162. 30 indexed citations

Overman, Michael J., Syed Mohammad Ali Kazmi, E. Lin, et al.. (2010). Weekly docetaxel, cisplatin, and 5‐fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer. 116(6). 1446–1453. 42 indexed citations

Agarwal, Banke, Arlene M. Correa, & Linus Ho. (2008). Survival in Pancreatic Carcinoma Based on Tumor Size. Pancreas. 36(1). e15–e20. 76 indexed citations

10.

Reyes‐Gibby, Cielito C., Wenyaw Chan, James L. Abbruzzese, et al.. (2007). Patterns of Self-Reported Symptoms in Pancreatic Cancer Patients Receiving Chemoradiation. Journal of Pain and Symptom Management. 34(3). 244–252. 46 indexed citations

11.

Kouvaraki, Maria A., Anita L. Korapati, George Z. Rassidakis, et al.. (2006). Potential Role of Jun Activation Domain–Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma. Cancer Research. 66(17). 8581–8589. 55 indexed citations

12.

Ajani, Jaffer A., Yixing Jiang, Josephine Faust, et al.. (2006). A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. Investigational New Drugs. 24(4). 353–357. 56 indexed citations

13.

Wong, Adrian, Robert A. Wolff, Douglas B. Evans, et al.. (2005). Radiation Dose Considerations in the Palliative Treatment of Locally Advanced Adenocarcinoma of the Pancreas. American Journal of Clinical Oncology. 28(3). 227–233. 9 indexed citations

14.

Zhang, Zhen, Zhongxing Liao, Jing Jin, et al.. (2005). Dose–response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 61(3). 656–664. 100 indexed citations

15.

Crane, Christopher H., Lee M. Ellis, M. OʼReilly, et al.. (2004). RhuMab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer: An active, well tolerated regimen. International Journal of Radiation Oncology*Biology*Physics. 60(1). S149–S149. 3 indexed citations

16.

Agarwal, Banke, et al.. (2004). Endoscopic Ultrasound-Guided Fine Needle Aspiration and Multidetector Spiral CT in the Diagnosis of Pancreatic Cancer. The American Journal of Gastroenterology. 99(5). 844–850. 233 indexed citations

17.

Agarwal, Banke, Stephen G. Swisher, Jaffer A. Ajani, et al.. (2004). Endoscopic Ultrasound after Preoperative Chemoradiation Can Help Identify Patients Who Benefit Maximally after Surgical Esophageal Resection. The American Journal of Gastroenterology. 99(7). 1258–1266. 32 indexed citations

18.

Esmaeli, Bita, et al.. (2002). Leiomyosarcoma of the Esophagus Metastatic to the Eyelid. Ophthalmic Plastic and Reconstructive Surgery. 18(2). 159–161. 16 indexed citations

19.

Ajani, Jaffer A., Jackie Baker, Peter W. T. Pisters, et al.. (2002). CPT‐11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma. Cancer. 94(3). 641–646. 121 indexed citations

20.

Ho, Linus, et al.. (2001). Malignant Pleural Mesothelioma. Cancer treatment and research. 105. 327–373. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact